Mattson Financial Services LLC Has $5.45 Million Stock Position in UnitedHealth Group Incorporated $UNH

Mattson Financial Services LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 15.2% in the 1st quarter, Holdings Channel.com reports. The fund owned 10,403 shares of the healthcare conglomerate’s stock after buying an additional 1,371 shares during the quarter. UnitedHealth Group comprises approximately 1.6% of Mattson Financial Services LLC’s investment portfolio, making the stock its 10th biggest position. Mattson Financial Services LLC’s holdings in UnitedHealth Group were worth $5,449,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. WBI Investments LLC acquired a new position in UnitedHealth Group in the 1st quarter valued at $316,000. Acadian Asset Management LLC raised its holdings in UnitedHealth Group by 150.9% in the 1st quarter. Acadian Asset Management LLC now owns 148,918 shares of the healthcare conglomerate’s stock valued at $77,984,000 after acquiring an additional 89,560 shares in the last quarter. Acorns Advisers LLC raised its holdings in UnitedHealth Group by 16.9% in the 1st quarter. Acorns Advisers LLC now owns 547 shares of the healthcare conglomerate’s stock valued at $286,000 after acquiring an additional 79 shares in the last quarter. Fortis Capital Advisors LLC raised its holdings in shares of UnitedHealth Group by 59.1% during the 1st quarter. Fortis Capital Advisors LLC now owns 619 shares of the healthcare conglomerate’s stock worth $324,000 after buying an additional 230 shares in the last quarter. Finally, Belpointe Asset Management LLC raised its holdings in shares of UnitedHealth Group by 3.6% during the 1st quarter. Belpointe Asset Management LLC now owns 9,114 shares of the healthcare conglomerate’s stock worth $4,774,000 after buying an additional 315 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.2%

NYSE UNH opened at $347.27 on Thursday. The business’s 50-day moving average price is $290.20 and its two-hundred day moving average price is $371.22. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a market capitalization of $314.51 billion, a PE ratio of 15.05, a price-to-earnings-growth ratio of 2.27 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the firm posted $6.80 EPS. The company’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft lowered their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. Raymond James Financial cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Finally, Wells Fargo & Company reduced their price objective on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $355.77.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.